Skip to main content

Advertisement

Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol

BMC Cancervolume 18, Article number: 110 (2018) | Download Citation

The original article was published in BMC Cancer 2017 17:549

Correction

After publication of the original article [1] the authors found that Table 2 had been formatted incorrectly, meaning that some rows in the Table did not display the correct information.

An updated version of Table 2 is included with this Correction.

Table 2 Used cognitive tests, questionnaires and biological tests
Full size table

The original article has also been updated.

Reference

  1. 1.

    Lange M, Laviec H, Castel H, Heutte N, Leconte A, Léger I, Giffard B, Capel A, Dubois M, Clarisse B, Coquan E, Di Fiore F, Gouérant S, Bartélémy P, Pierard L, Karim F, Joly F. Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol. BMC Cancer. 2017;17:549. https://doi.org/10.1186/s12885-017-3534-8.

Download references

Author information

Affiliations

  1. INSERM, U1086 ANTICIPE, Normandie University, UNICAEN, 14076, Caen, France

    • Marie Lange
    • , Natacha Heutte
    • , Isabelle Léger
    •  & Florence Joly

  2. Clinical Research Department, Centre François Baclesse, 14076, Caen, France

    • Marie Lange
    • , Natacha Heutte
    • , Alexandra Leconte
    • , Aurélie Capel
    • , Bénédicte Clarisse
    • , Elodie Coquan
    •  & Florence Joly

  3. Cancer and Cognition Platform, Ligue Nationale Contre le Cancer, 14076, Caen, France

    • Marie Lange
    • , Hélène Castel
    • , Isabelle Léger
    • , Bénédicte Giffard
    • , Martine Dubois
    •  & Florence Joly

  4. Medical Oncology Department, Centre François Baclesse, 14076, Caen, France

    • Heidi Laviec
    •  & Elodie Coquan

  5. Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Normandie University, UNIROUEN, INSERM, DC2N, 76000, Rouen, France

    • Hélène Castel
    •  & Martine Dubois

  6. UPO, Gustave Roussy, 94800, Villejuif, France

    • Isabelle Léger

  7. NeuroHIV Rehabilitation Unit, Bicêtre University Hospital, 94275, Le Kremlin Bicêtre, France

    • Isabelle Léger

  8. Normandie University, UNICAEN, EPHE Paris, INSERM, U1077, 14000, Caen, France

    • Bénédicte Giffard

  9. Medical Oncology Department, Centre Henri-Becquerel, 76000, Rouen, France

    • Frédéric Di Fiore
    •  & Sophie Gouérant

  10. Digestive and Urology Oncology Unit, Rouen University Hospital, 76000, Rouen, France

    • Frédéric Di Fiore
    •  & Sophie Gouérant

  11. Medical Oncology and Hematology Department, Hôpitaux Universitaires de Strasbourg, 67000, Strasbourg, France

    • Philippe Bartélémy
    •  & Laure Pierard

  12. Medical Oncology Department, Gustave Roussy, 94800, Villejuif, France

    • Karim Fizazi

  13. Medical Oncology Department, CHU de Caen, 14000, Caen, France

    • Florence Joly

Authors

  1. Search for Marie Lange in:

  2. Search for Heidi Laviec in:

  3. Search for Hélène Castel in:

  4. Search for Natacha Heutte in:

  5. Search for Alexandra Leconte in:

  6. Search for Isabelle Léger in:

  7. Search for Bénédicte Giffard in:

  8. Search for Aurélie Capel in:

  9. Search for Martine Dubois in:

  10. Search for Bénédicte Clarisse in:

  11. Search for Elodie Coquan in:

  12. Search for Frédéric Di Fiore in:

  13. Search for Sophie Gouérant in:

  14. Search for Philippe Bartélémy in:

  15. Search for Laure Pierard in:

  16. Search for Karim Fizazi in:

  17. Search for Florence Joly in:

Corresponding author

Correspondence to Florence Joly.

Additional information

The online version of the original article can be found under https://doi.org/10.1186/s12885-017-3764-9

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

BMC Cancer

ISSN: 1471-2407

Contact us